Ann-Kathrin Zaum

Dr. Ann-Kathrin Zaum


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Neuromuscular Disorders
Verified
Journal Article
Closed access
AZAnn-Kathrin Zaum
Ann-Kathrin Zaum
BSBurkhard Stüve
Burkhard Stüve
AGAndrea Gehrig
Andrea Gehrig
HKHeike Kölbel
Heike Kölbel
USUlrike Schara
Ulrike Schara
SRSimone Rost
Simone Rost

13 October 2016 in Journal of Neurology
Verified
Journal Article
Closed access
PDF file
TMThomas Musacchio
Thomas Musacchio
AZAnn-Kathrin Zaum
Ann-Kathrin Zaum
NÜNurcan Üçeyler
Nurcan Üçeyler
CSClaudia Sommer
Claudia Sommer
NPNora Pfeifroth
Nora Pfeifroth
SKStephan Klebe
Stephan Klebe

1 August 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
AZAnn-Kathrin Zaum
Ann-Kathrin Zaum
INIndrajit Nanda
Indrajit Nanda
WKWolfram Kress
Wolfram Kress
SRSimone Rost
Simone Rost
Background: Dystrophinopathies caused by variants in the DMD gene are a well‐studied muscle disease. The most common type of variant in DMD are large deletions. Very rarely reported forms of variants are chromosomal translocations, inversions and deep intronic variants (DIVs) because they are not detectable by standard diagnostic techniques (sequencing of coding sequence, copy number variant detection). This might be the reason that some clinically and histologically proven dystrophinopathy cases remain unsolved.Methods: We used whole genome sequencing (WGS) to screen the entire DMD gene for variants in one of two brothers suffering from typical muscular dystrophy with strongly elevated creatine kinase levels.Results: Although a pathogenic DIV could not be detected, we were able to identify a pericentric inversion with breakpoints in DMD intron 44 and Xq13.3, which could be confirmed by Sanger sequencing in the index as well as in his brother and mother. As this variation affects a major part of DMD it is most likely disease causing.Conclusion: Our findings elucidate that WGS is capable of detecting large structural rearrangements and might be suitable for the genetic diagnostics of dystrophinopathies in the future. In particular, inversions might be a more frequent cause for dystrophinopathies as anticipated and should be considered in genetically unsolved dystrophinopathy cases.

Verified
Journal Article
Open access
PDF file
NPNatalie Pluta
Natalie Pluta
AMArpad von Moers
Arpad von Moers
APAstrid Pechmann
Astrid Pechmann
WSWerner Stenzel
Werner Stenzel
HGHans-Hilmar Goebel
Hans-Hilmar Goebel
SRSimone Rost
Simone Rost
Dystrophinopathies are the most common muscle diseases, especially in men. In women, on the other hand, a manifestation of Duchenne muscular dystrophy is rare due to X-chromosomal inheritance. We present two young girls with severe muscle weakness, muscular dystrophies, and creatine kinase (CK) levels exceeding 10,000 U/L. In the skeletal muscle tissues, dystrophin staining reaction showed mosaicism. The almost entirely skewed X-inactivation in both cases supported the possibility of a dystrophinopathy. Despite standard molecular diagnostics (including multiplex ligation-dependent probe amplification (MLPA) and next generation sequencing (NGS) gene panel sequencing), the genetic cause of the girls’ conditions remained unknown. However, whole-genome sequencing revealed two reciprocal translocations between their X chromosomes and chromosome 5 and chromosome 19, respectively. In both cases, the breakpoints on the X chromosomes were located directly within the DMD gene (in introns 54 and 7, respectively) and were responsible for the patients’ phenotypes. Additional techniques such as Sanger sequencing, conventional karyotyping and fluorescence in situ hybridization (FISH) confirmed the disruption of DMD gene in both patients through translocations. These findings underscore the importance of accurate clinical data combined with histopathological analysis in pinpointing the suspected underlying genetic disorder. Moreover, our study illustrates the viability of whole-genome sequencing as a time-saving and highly effective method for identifying genetic factors responsible for complex genetic constellations in Duchenne muscular dystrophy (DMD).

28 September 2022 in Genes
Verified
Journal Article
Open access
PDF file
NPNatalie Pluta
Natalie Pluta
SHSabine Hoffjan
Sabine Hoffjan
FZFrederic Zimmer
Frederic Zimmer
CKCornelia Köhler
Cornelia Köhler
TLThomas Lücke
Thomas Lücke
SRSimone Rost
Simone Rost
New techniques in molecular genetic diagnostics now allow for accurate diagnosis in a large proportion of patients with muscular diseases. Nevertheless, many patients remain unsolved, although the clinical history and/or the muscle biopsy give a clear indication of the involved genes. In many cases, there is a strong suspicion that the cause must lie in unexplored gene areas, such as deep-intronic or other non-coding regions. In order to find these changes, next-generation sequencing (NGS) methods are constantly evolving, making it possible to sequence entire genomes to reveal these previously uninvestigated regions. Here, we present a young woman who was strongly suspected of having a so far genetically unsolved sarcoglycanopathy based on her clinical history and muscle biopsy. Using short read whole genome sequencing (WGS), a homozygous inversion on chromosome 13 involving SGCG and LINC00621 was detected. The breakpoint in intron 2 of SGCG led to the absence of γ-sarcoglycan, resulting in the manifestation of autosomal recessive limb-girdle muscular dystrophy 5 (LGMDR5) in the young woman.

29 November 2024 in Biomedicines
Verified
Journal Article
Open access
PDF file
KNKatja Neuhoff
Katja Neuhoff
OKOzge Aksel Kilicarslan
Ozge Aksel Kilicarslan
CPCorinna Preusse
Corinna Preusse
AZAnn-Kathrin Zaum
Ann-Kathrin Zaum
HKHeike Kölbel
Heike Kölbel
AGAndrea Gangfuß
Andrea Gangfuß
Background/Objectives: X-linked dystrophinopathies are a group of neuromuscular diseases caused by pathogenic variants in the DMD gene (MIM *300377). Duchenne muscular dystrophy (DMD; MIM #310200) is the most common inherited muscular dystrophy. Methods: We screened datasets of 403 male, genetically confirmed X-linked dystrophinopathy patients and identified 13 pathogenic variants of the DMD gene that have not been described in the literature thus far. For all patients we provide additional data on the clinical course, genotype–phenotype correlations as well as histological datasets of nine patients. In two cases, we used RNA-Seq analyses, showing that this method can be particularly helpful in cases of deep intrinsic variants. Results: We were able to show, that a combination of the different datasets is helpful to counsel families and provides a better understanding of the underlying pathophysiology. Conclusions: Overall, we elaborated upon the persistent challenge of determining the course of disease from genetic analysis alone, rather supporting the concept of a clinical continuum of dystrophinopathies with our combined clinical, histological and molecular genetic findings.